In this regard, when combined with PPARγ agonists such as troglitazone (TGZ), ATRA synergistically and irreversibly inhibits growth and induces apoptosis in human breast cancer cells (Elstner et al, 1998). This evidence concerns the gene PPARG and breast carcinoma.